Greg Worrell
Professor Neurology & Division Chair of Clinical Neurophysiology @ Mayo Clinic Ventures
Rochester, United States
Greg Worrell is a Series A investor at Mayo Clinic Ventures in Rochester focused on Health Care and Neuroscience. Greg Worrell
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Greg Worrell invests in
Stages Greg Worrell invests in
Countries Greg Worrell invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (100%)
- Neuroscience 1 (100%)
- Therapeutics 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy, central pain, and other neurological disorders. The company's core technology has been developed at Mayo Clinic and is under clinical evaluation. Its medical device therapies provide medical practitioners with the procedurethat can be used to tailor brain stimulation therapy to each individual and enhance seizure control compared to currently used protocols.Cadence Neuroscience was established in 2017 and is headquartered in Redmond, Washington. | $15M / Series A / Oct 11, 2019 |
Co-Investors
About Mayo Clinic Ventures
Mayo Clinic Ventures is dedicated to quickly bringing answers to the people who need them most: the patients living with diseases and conditions that threaten to limit or even end their lives. Our team works closely with Mayo physicians and scientists to mine inventions, ideas and discoveries that will truly transform health care. Their dedicatedefforts bring significant financial support to Mayo's patient care, education and research efforts.
Mayo Clinic Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andrew Badley
Professor & Chair, Dept of Molecular Medicine
|
|||
|
Greg Worrell
Professor Neurology & Division Chair of Clinical Neurophysiology
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Greg Worrell invest in?
Greg Worrell invests primarily in Health Care, Neuroscience and Therapeutics startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Greg Worrell?
Public channels for Greg Worrell include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Greg Worrell last invest?
The most recent investment recorded for Greg Worrell closed in Oct 2019. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
